Pure Cusp Tear of Trifecta Bioprosthesis 2 Years after Aortic Valve Replacement

Ann Thorac Cardiovasc Surg. 2017 Jun 20;23(3):157-160. doi: 10.5761/atcs.cr.16-00183. Epub 2016 Dec 14.

Abstract

Trifecta is a stented bioprosthetic heart valve with a bovine pericardial sheet externally mounted on a titanium stent. This valve is applied only for aortic valve replacement (AVR), providing excellent hemodynamics and extremely low incidence of structural valve deterioration (SVD). A 76-year-old woman presented with dyspnea on effort 24 months after AVR with a 21-mm Trifecta valve. Echocardiography revealed severe aortic regurgitation with prolapse of a cusp of Trifecta valve, which suggested that she developed acute heart failure due to early SVD. In the operation, Trifecta valve had a cusp tear near the commissure with circumferential fibrous pannus ingrowth only at the inflow side. There was neither calcification nor infection. The Trifecta valve was successfully replaced with a new porcine bioprosthesis.

Keywords: Trifecta; aortic valve replacement; pericardial bioprosthesis; structural valve deterioration.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged
  • Aortic Valve / diagnostic imaging
  • Aortic Valve / physiopathology
  • Aortic Valve / surgery*
  • Aortic Valve Insufficiency / diagnostic imaging
  • Aortic Valve Insufficiency / etiology*
  • Aortic Valve Insufficiency / physiopathology
  • Aortic Valve Insufficiency / surgery
  • Bioprosthesis*
  • Device Removal
  • Echocardiography, Doppler, Color
  • Female
  • Heart Valve Prosthesis Implantation / adverse effects
  • Heart Valve Prosthesis Implantation / instrumentation*
  • Heart Valve Prosthesis*
  • Humans
  • Prosthesis Design
  • Prosthesis Failure*
  • Severity of Illness Index
  • Time Factors
  • Treatment Outcome